INTEST CORP Financial Summary

Quick Answer

INTEST CORP reported Total Revenue of $66.80 million for fiscal year 2017.

INTEST CORP — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue
Net Income -$2.53M
-187.4%
$2.89M
-69.1%
$9.34M
+10.4%
$8.46M
+16.2%
$7.28M
+913.7%
-$895.0K
-138.5%
Diluted EPS -$0.21
-187.5%
$0.24
-69.6%
$0.79
+1.3%
$0.78
+14.7%
$0.68
+855.6%
-$0.09
-140.9%
Total Assets $151.31M
-0.6%
$152.29M
+12.9%
$134.83M
+22.5%
$110.07M
+5.9%
$103.91M
+67.5%
$62.03M
+3.9%
Cash and Equivalents $14.22M
-28.3%
$19.83M
-56.2%
$45.26M
+236.9%
$13.43M
-36.6%
$21.20M
+106.2%
$10.28M
+35.0%
Long-Term Debt $1.41M
-81.3%
$7.54M
-5.1%
$7.94M
-34.0%
$12.04M
-24.7%
$16.00M $0.00
Stockholders Equity $103.62M
+3.8%
$99.79M
+3.6%
$96.28M
+48.2%
$64.96M
+18.5%
$54.82M
+22.5%
$44.75M
-0.2%
R&D Expense $9.44M
+10.4%
$8.55M
+12.2%
$7.62M
+1.2%
$7.53M
+36.1%
$5.53M
+9.1%
$5.07M
+2.1%
Operating Income -$3.73M
-209.8%
$3.39M
-67.5%
$10.44M
-2.6%
$10.72M
+26.7%
$8.46M
+795.1%
-$1.22M
-147.7%
Gross Profit $48.92M
-11.7%
$55.42M
-2.7%
$56.98M
+6.6%
$53.44M
+29.6%
$41.22M
+71.0%
$24.10M
-17.5%
Shares Outstanding 12.49M
+0.9%
12.38M
+1.7%
12.17M

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2017 $17.35M +60.3% +9.2%
Net Income September 30, 2025 -$938.0K -289.5% -86.5%
Diluted EPS September 30, 2025 -$0.08 -300.0% -100.0%
Total Assets September 30, 2025 $148.28M -6.4% -0.9%
Cash and Equivalents September 30, 2025 $16.23M -9.7% -15.7%
Long-Term Debt September 30, 2025 $2.34M -70.1% -36.3%
Stockholders Equity September 30, 2025 $101.87M +1.5% -0.7%
R&D Expense September 30, 2025 $2.33M +7.0% +4.0%
Operating Income September 30, 2025 -$1.19M -345.0% -28.7%
Gross Profit September 30, 2025 $10.99M -21.6% -8.2%
Shares Outstanding September 30, 2025 12.48M +0.0%
  • INTEST CORP reported Total Revenue of $66.80 million for fiscal year 2017.
  • INTEST CORP showed an increase of +66.1% in Total Revenue compared to the prior fiscal year.
  • INTEST CORP reported Net Income of -$2.53 million for fiscal year 2025.
  • INTEST CORP showed a decrease of -187.4% in Net Income compared to the prior fiscal year.
  • INTEST CORP reported Diluted EPS of $0.21 per share (loss) for fiscal year 2025.
  • INTEST CORP showed a decrease of -187.5% in Diluted EPS compared to the prior fiscal year.
  • INTEST CORP reported Total Assets of $151.31 million for fiscal year 2025.
  • INTEST CORP showed a decrease of -0.6% in Total Assets compared to the prior fiscal year.
  • INTEST CORP reported Cash and Equivalents of $14.22 million for fiscal year 2025.
  • INTEST CORP showed a decrease of -28.3% in Cash and Equivalents compared to the prior fiscal year.
  • INTEST CORP reported Long-Term Debt of $1.41 million for fiscal year 2025.
  • INTEST CORP showed a decrease of -81.3% in Long-Term Debt compared to the prior fiscal year.
  • INTEST CORP reported Stockholders Equity of $103.62 million for fiscal year 2025.
  • INTEST CORP showed an increase of +3.8% in Stockholders Equity compared to the prior fiscal year.
  • INTEST CORP reported R&D Expense of $9.44 million for fiscal year 2025.
  • INTEST CORP showed an increase of +10.4% in R&D Expense compared to the prior fiscal year.
  • INTEST CORP reported Operating Income of -$3.73 million for fiscal year 2025.
  • INTEST CORP showed a decrease of -209.8% in Operating Income compared to the prior fiscal year.
  • INTEST CORP reported Gross Profit of $48.92 million for fiscal year 2025.
  • INTEST CORP showed a decrease of -11.7% in Gross Profit compared to the prior fiscal year.
  • INTEST CORP reported Shares Outstanding of 12.49 million shares for fiscal year 2025.
  • INTEST CORP showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment